Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Convertible Debt: 2021

Historic Convertible Debt for China Pharma Holdings (CPHI) over the last 1 years, with Dec 2021 value amounting to $5.2 million.

  • China Pharma Holdings' Convertible Debt was N/A to $4.8 million in Q2 2022 from the same period last year, while for Jun 2022 it was $4.8 million, marking a year-over-year change of. This contributed to the annual value of $5.2 million for FY2021, which is N/A change from last year.
  • According to the latest figures from FY2021, China Pharma Holdings' Convertible Debt is $5.2 million.
  • China Pharma Holdings' 5-year Convertible Debt high stood at $5.2 million for FY2021, and its period low was $5.2 million during FY2021.
  • Moreover, its 1-year median value for Convertible Debt was $5.2 million (2021), whereas its average is $5.2 million.